Mutations in the KRAS gene are one of the most frequent genetic abnormalities in ovarian cancer, and are more frequently present in carcinoma of a lower grade and International Federation of Gynecology and Obstetrics (FIGO) stage, and in lesions of a mucinous histotype [17]. The gene discussed is KRAS; the disease is ovarian cancer.